Biocon

Biocon To Buy 26% Stake In Hinduja Renewables Two

Business | Edited by Peter Noronha | Tuesday November 24, 2020

"The cost of the acquisition is Rs 5,91,61,730 for the acquisition of 26 per cent stake on a fully diluted basis in one or more tranches," the Bangalore-based Biocon said in a BSE filing.

Stocks To Watch: Reliance Industries, Coal India, Biocon In Focus Today

Business | Edited by Sandeep Singh (with inputs from agencies) | Tuesday November 24, 2020

Stocks To Watch: Reliance Industries shares will be watched after the conglomerate said its subsidiary, Jio Platforms, received the subscription amount of Rs 33,737 crore from Google International LLC.

Biocon To Spend Rs 65 Crore On Metro Station At Bengaluru's Hebbagodi

Bangalore News | Written by Maya Sharma | Thursday October 8, 2020

The Namma Metro project in Bengaluru received a financial boost from the city's Biocon Foundation, headed by Dr Kiran Mazumdar Shaw.

"Have Added To Covid Count...": Kiran Mazumdar Shaw Tests Positive

India News | Reported by Maya Sharma, Edited by Debanish Achom | Tuesday August 18, 2020

Kiran Mazumdar Shaw has tested positive for coronavirus, the chief of biopharmaceutical firm Biocon has tweeted. "I have added to the Covid count by testing positive. Mild symptoms n I hope it stays that way," Kiran Mazumdar Shaw tweeted on Monday night.

Biocon Soars Nearly 10% On Receiving Nod For Covid-19 Drug

Business | Edited by Peter Noronha | Monday July 13, 2020

Biocon Share: Biocon received approval from the Drugs Controller General of India to market its novel biologic drug Itolizumab for treating patients having Covid-19 complications.

Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients

Business | Reuters | Sunday July 12, 2020

The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.

Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment

Business | Edited by Peter Noronha | Wednesday May 27, 2020

The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.

"Good To Be Back": Kiran Mazumdar Shaw Attends Office For First Time Since March

India News | Edited by Arun Nair | Friday May 15, 2020

The Biocon chief had last attended the office on March 24. A day later, Prime Minister Narendra Modi had announced a nationwide lockdown to control the spread of coronavirus. All but essential services were shut across the country, effectively putting over a billion people indoor.

"Our Economic Cancer Needs...": Biocon Chief Kiran Shaw Ahead Of Budget

India News | Edited by Chandrashekar Srinivasan | Saturday February 1, 2020

Biocon chief Kiran Shaw tweeted ahead of the Union Budget - to be presented by Finance Minister Nirmala Sitharaman -, describing the slowdown as "cancer" and urging the government to treat it with "immunotherapy not chemotherapy"

"Not Surprising", Says Kiran Shaw On IMF Prediction Of India Slowdown

India News | Reported by Nidhi Razdan, Edited by Anindita Sanyal | Tuesday January 21, 2020

Biocon chief Kiran Shaw today said the International Monetary Fund's markdown of India's growth story is not surprising and the government needs to focus on investments and exports. There is also a need to bridge the trust deficit to bring back investment.

Kiran Mazumdar-Shaw Conferred With Australia's Highest Civilian Honour

India News | Written by Maya Sharma | Friday January 17, 2020

Biocon founder Dr Kiran Mazumdar-Shaw was conferred with Australia's highest civilian honour, the Order of Australia honour, at a ceremony in Bengaluru on Friday.

India Inc's Kiran Shaw And Mohandas Pai Swap Tweets On Deepika Padukone

India News | Edited by Anindita Sanyal | Monday January 13, 2020

Former Infosys director Mohandas Pai and Biocon chief Kiran Mazumdar Shaw sparred on Twitter on Sundayover actor Deepika Padukone's visit to Jawaharlal Nehru University to show silent support with the assaulted students.

"Looks Like Diwali Has Come Early": India Inc. Cheers Corporate Tax Cut

India News | Edited by Arun Nair | Friday September 20, 2019

The centre's decision to reduce corporate tax for domestic companies was welcomed across the industry, with Biocon chairman Kiran Mazumdar Shaw saying that the move signals government's commitment to spur economic growth and "support legitimate tax abiding companies".

A Twitter Exchange Between Nirmala Sitharaman And Kiran Mazumdar Shaw

India News | Edited by Deepshikha Ghosh | Thursday September 19, 2019

In an exchange on Twitter, Finance Minister Nirmala Sitharaman rebutted Kiran Mazumdar Shaw as she wondered why the ban on e-cigarettes, approved on Wednesday by the cabinet, had not been announced by the Health Minister.

Government Failed To Stop Tax Terrorism: Mohandas Pai To NDTV

India News | Edited by Anindita Sanyal | Sunday August 4, 2019

The issue of entrepreneurs facing tax terrorism - raised first by Cafe Coffee Day promoter VG Siddharth before his death - has now been reinforced by former Infosys director Mohandas Pai and Biocon chief Kiran Mazumdar Shaw.